Astrocyte Senescence as a Component of Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
Aging is the main risk factor for Alzheimer's disease (AD); however, the aspects of the aging process that predispose the brain to the development of AD are largely unknown. Astrocytes perform a myriad of functions in the central nervous system to maintain homeostasis and support neuronal function. In vitro, human astrocytes are highly sensitive to oxidative stress and trigger a senescence program when faced with multiple types of stress. In order to determine whether senescent astrocytes appear in vivo, brain tissue from aged individuals and patients with AD was examined for the presence of senescent astrocytes using p16(INK4a) and matrix metalloproteinase-1 (MMP-1) expression as markers of senescence. Compared with fetal tissue samples (n = 4), a significant increase in p16(INK4a)-positive astrocytes was observed in subjects aged 35 to 50 years (n = 6; P = 0.02) and 78 to 90 years (n = 11; P<10(-6)). In addition, the frontal cortex of AD patients (n = 15) harbored a significantly greater burden of p16(INK4a)-positive astrocytes compared with non-AD adult control subjects of similar ages (n = 25; P = 0.02) and fetal controls (n = 4; P<10(-7)). Consistent with the senescent nature of the p16(INK4a)-positive astrocytes, increased metalloproteinase MMP-1 correlated with p16(INK4a). In vitro, beta-amyloid 1-42 (Aβ(1-42)) triggered senescence, driving the expression of p16(INK4a) and senescence-associated beta-galactosidase. In addition, we found that senescent astrocytes produce a number of inflammatory cytokines including interleukin-6 (IL-6), which seems to be regulated by p38MAPK. We propose that an accumulation of p16(INK4a)-positive senescent astrocytes may link increased age and increased risk for sporadic AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In many prevalent neurodegenerative conditions including Alzheimer's Disease, brain tissue biopsies are present with increased levels of p16INK4a- positive astrocytes, MMP-1 and IL-6”
From Redox control of senescence and age-related disease. (2017) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Astrocytes cultured from patients with AD express not only more of the CDKi p16 INK4A than age-matched controls, but also more MMP1 and IL-6 (57).”
From Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives (2018) · cites this paper as [57]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies have highlighted senescence in multiple brain cell types in AD [3, 16, 32, 52, 80].”
From Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics (2024) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In the context of aging and neurodegenerative disease, senescent cell accumulation has been identified in multiple cell types within the central nervous system (CNS), including neurons6,7,14,15, astrocytes16,17, microglia8,18, oligodendrocyte precursor cells19 and endothelial cells20.”
From Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial (2023) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Furthermore, prior research conducted on postmortem brain tissue from individuals with AD has identified senescent astrocytes16, and mouse models have demonstrated that they are cleared with senolytic treatment8,17.”
From Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial (2023) · cites this paper as [16]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 1×
“Staining for Senescence-associated b-galactosidase Senescence-associated beta-galactosidase (SA b-gal) staining was performed as previously described [62].”
MethodThe senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 11×
“One component of the SASP present in multiple cell types is IL-6.”
BackgroundInfluentialAstrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196 · cited 1×
“Astrocytes regulate the contents of the synaptic cleft and synaptic transmission as part of the tripartite synapse, control CNS metabolism, and maintain blood brain barrier integrity [10,11].”
BackgroundWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“The increased dosage of synthetic versus cell-derived Ab oligomers required to trigger senescence, correlates with reports on the effects of Ab on rat hippocampal long-term potentiation [53].”
BackgroundShankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“demonstrated by the phenotypic improvement observed following the targeted removal of senescent cells in a progeroid mouse model [9].”
BackgroundInfluentialMechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580 · cited 1×
“In vitro, we found that exposure of astrocytes to Ab1–42 triggers senescence and that senescent astrocytes produce high quantities of interleukin-6 (IL-6), a cytokine known to be increased in the CNS of AD patients [18].”
Background2013 Alzheimer's disease facts and figures
Alzheimer's Association, Thies, W., & Bleiler, L. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.02.003 · Cited by 3,328
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 1×
“We selected the age ranges of 35–50 years and 78–90 years (Figure 3B) in order to compare a group that is least likely to have AD and a group that is most likely to have AD [31].”
MethodBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Cited by
Items 401–500 of 589
Manavi, Z., Melchor, G. S., Bullard, M. R., Gross, P. S., Ray, S., Gaur, P., Baydyuk, M., & Huang, J. K. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03425-3 · Cited by 10
Targeted Therapeutics Delivery by Exploiting Biophysical Properties of Senescent Cells
Low, J., Chan, B., & Tay, A. K. P. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202107990 · Cited by 11
The Biocompatibility of Wireless Power Charging System on Human Neural Cells
Škovierová, H., Pavelek, M., Okajčeková, T., Pálešová, J., Strnádel, J., Špánik, P., Halášová, E., & Frivaldský, M. (2021) · Applied Sciences · doi:10.3390/app11083611 · Cited by 10
Involvement of astrocyte senescence in Alzheimer's disease
Tüzer, F., & Torres, C. A. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102594 · Cited by 13
Self-citationGonzález‐Puertos, V. Y., Maciel-Barón, L. Á., Barajas-Gómez, B. A., López‐Díazguerrero, N. E., & Königsberg, M. (2015) · PubMed · Cited by 18
Cellular senescence in neurodegenerative diseases
Zhang, P., & Sung, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00012-2 · Cited by 10
Radiation-Induced Brain Injury with Special Reference to Astrocytes as a Therapeutic Target
Wang, C., Fan, X., Shi, Y., & Tang, F. R. (2025) · Journal of Integrative Neuroscience · doi:10.31083/jin25907 · Cited by 12
Abedin, M. J., & Kastanenka, K. V. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251411561 · Cited by 11
Cell ageing: a flourishing field for neurodegenerative diseases
Brites, D. M. T. O. (2015) · AIMS molecular science · doi:10.3934/molsci.2015.3.225 · Cited by 11
“It is now accepted that the senescent cells are functionally altered and their number increase with ageing [22,23,24].”
BackgroundWaaijer, M. E. C., Westendorp, R. G. J., Goldeck, D., Gunn, D. A., Pawelec, G., Stijntjes, M., Slagboom, P. E., & Maier, A. B. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.03.020 · Cited by 10
“, 2006) and to age-related pathologies (Bhat et al., 2012; Verzola et al., 2008; Sis et al., 2007; Tsuji et al., 2006), but most studies have a modest sample size and studies on disease rarely adjust for age.”
BackgroundEarly Chronic Stress Induced Changes within the Locus Coeruleus in Sporadic Alzheimer’s Disease
Minné, D., Marnewick, J. L., & Engel-Hills, P. C. (2023) · Current Alzheimer Research · doi:10.2174/1567205020666230811092956 · Cited by 11
Mechanisms of Transsynaptic Degeneration in the Aging Brain
Wall, R. V., Basavarajappa, D. K., Klistorner, A. I., Graham, S. L., & You, Y. (2024) · Aging and Disease · doi:10.14336/ad.2024.03019 · Cited by 11
“…extracellular deposition of beta amyloid (Aβ) peptide and intra-neuronal accumulation of phosphorylated Tau, in vitro studies indicate that these two peptides can cause a healthy astrocyte to become senescent., Further, AD sufferers showing greater senescence than age-matched counterparts [90, 98].”
BackgroundSalmina, A. B., Komleva, Y. K., Kuvacheva, N. V., Lopatina, O. L., Пожиленкова, Е. А., Gorina, Y. V., Gasymly, E. D., Panina, Y. A., Morgun, A. V., & Malinovskaya, N. A. (2015) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn.v70i1.1227 · Cited by 12
“Более того, инсулин все чаще рассматривают в качестве гормона с противовоспалительной активностью [65], что открывает новые подходы к интерпретации процессов, лежащих в основе формирования инсулинорезистетности при старении или нейровоспалении.”
The Senescence Arrest Program and the Cell Cycle
Bitto, A., Crowe, E. P., Lerner, C. A., Torres, C. A., & Sell, C. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0888-2_8 · Cited by 9
Self-citationA Proteomic Atlas of Senescence-Associated Secretomes for Aging Biomarker DevelopmentPreprint
Basisty, N., Kale, A., Jeon, O. H., Kuehnemann, C., Payne, T., Rao, C., Holtz, A. N., Shah, S., Ferrucci, L., Campisi, J., et al. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3380253 · Cited by 18
Development of an accelerated cellular model for early changes in Alzheimer’s disease
Xue, H., Gate, S., Gentry, E., Losert, W., & Cao, K. (2023) · Scientific Reports · doi:10.1038/s41598-023-45826-5 · Cited by 9
“It is reported that increased p16 and cdk4/6 are associated with cell cycle dysregulation in AD 57,58 .”
BackgroundNetwork of extracellular vesicles surrounding senescent cells
Okawa, H., Tanaka, Y., & Takahashi, A. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.109953 · Cited by 8
Senescent microglia: The hidden culprits accelerating Alzheimer’s disease
Li, W., Xie, Y., Jia-Xin, M., Shu-Chao, G., & Li-Ping, H. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149480 · Cited by 11
Interplay Between Aging and Glial Cell Dysfunction: Implications for CNS Health
García‐Domínguez, M. (2025) · Life · doi:10.3390/life15101498 · Cited by 17
“This SASP includes the production and secretion of some pro-inflammatory cytokines (e.g., IL-6 and IL-8), chemokines (e.g., CXCL10), growth factors (e.g., TGF-β ), and matrix metalloproteinases (e.g., MMP-3 and MMP-9) [101,102].”
Singh, I., & Singh, A. K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05504-1 · Cited by 11
“These findings suggest that a wide variety of cells are affected in the brain by senescence and that they transmit these characteristics to neighboring healthy cells [39].”
de Oliveira, L. R., Mombach, J. C. M., & Castellani, G. (2015) · Molecular BioSystems · doi:10.1039/c5mb00230c · Cited by 7
Frentizole derivatives with mTOR inhibiting and senomorphic properties
Chrienová, Ž., Rysanek, D., Novak, J. F., Vašicová, P., Olekšák, P., Andrýs, R., Skarka, A., Dumanovic, J., Milovanovic, Z. A., Jacevic, V. M., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115600 · Cited by 9
“Senescent cells are thought to contribute to aging and age-associated diseases, including AD (see, e.g., [42,43]).”
BackgroundLevit, A., Cheng, S., Hough, O., Liu, Q., Ağca, Y., Agca, C., Hachinski, V., & Whitehead, S. N. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00082 · Cited by 9
“The role of transgenic hAPP in the insufficient response of TgAPP21 astrocytes is supported by previous findings of amyloid overwhelming astrocytes and inducing senescence in astrocytes (Bhat et al., 2012; Söllvander et al., 2016).”
BackgroundSenescent Cell-Secreted Netrin-1 Modulates Aging-Related Disorders by Recruiting Sympathetic Fibers
Yu, A. Q., Wang, J., Zhou, X. J., Chen, K. Y., Cao, Y. D., Wang, Z. X., & Mao, Z. B. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.507140 · Cited by 10
“Significantly, several lines of evidence have revealed that cellular senescence is closely associated with aging-related diseases, including osteoarthritis (OA), atherosclerosis, cancer, Parkinson’s disease, Alzheimer’s disease, and type 2 diabetes (Bhat et al., 2012; Childs et al., 2016; Calcinotto et al., 2019).”
BackgroundChiarini, A., Armato, U., Gui, L., Yin, M., Chang, S., & Prà, I. D. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149283 · Cited by 9
“Senescent HCAs occur in aging brains (Salminen et al., 2011) and in AD and other neurodegenerative diseases brains (Bhat et al., 2012) and support neuroinflammation and cognitive decline (Salas-Venegas et al., 2023).”
Horikawa, I., Yamada, L., Harris, B. T., & Harris, C. C. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.06.031 · Cited by 7
Carvalho, D. B., Díaz‐Amarilla, P., Dapueto, R., Santi, M. D., Duarte, P., Savio, E., Engler, H., Abin‐Carriquiry, J. A., & Arredondo, F. (2023) · Journal of Molecular Neuroscience · doi:10.1007/s12031-023-02105-2 · Cited by 8
“Marker and related proteins were gathered from literature sources (Bhat et al. 2012; Crowe et al. 2016; Casella et al. 2019; Basisty et al. 2020a, b; González-Gualda et al. 2021) (see full list and references in Online Resource 2) et al. 2006).”
BackgroundMethodInfluentialTan, X., Su, X., Wang, Y., Liang, W., Wang, D., Huo, D., Wang, H., Qi, Y., Zhang, W., Han, L., et al. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.11.004 · Cited by 8
Clusterin Deficiency Promotes Cellular Senescence in Human Astrocytes
Sultana, P., Honc, O., Hodný, Z., & Novotný, J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04650-2 · Cited by 7
“Aging biomarkers such as p16 have been found to be elevated in aged cortices, and p16 is overexpressed in the frontal cortex of Alzheimer’s disease patients [22].”
Elimination of senescent cells prevents neurodegeneration in mice
Penney, J., & Tsai, L. (2018) · Nature · doi:10.1038/d41586-018-06677-7 · Cited by 7
YAP: a novel target for Alzheimer's disease
Xu, X., Wang, Y., & Huang, Z. (2022) · Aging · doi:10.18632/aging.204045 · Cited by 8
New Insight in The Molecular Mechanisms of Neurodegenerative Disease
Meiliana, A., Dewi, N. M., & Wijaya, A. (2018) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v10i1.448 · Cited by 8
Wang, S., Li, B., Cai, Z., Hugo, C., Li, J., Sun, Y. E., Lü, Q., Remaley, A. T., Julia, T. C. W., Chui, H. C., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4373201/v1 · Cited by 7
“Amyloid beta (Aβ) and tau accumulation are major inducers of cellular senescence in AD [11, 62], and the removal of senescent cells has been shown to alleviate AD pathology and enhance memory in AD mouse models [12, 13].”
Li, Y., & Yang, X. (2024) · Cognitive Neurodynamics · doi:10.1007/s11571-024-10064-6 · Cited by 8
Ristori, S., Bertoni, G., Bigi, A., Cecchi, C., Sollazzo, M., Iommarini, L., Monti, D., & Bientinesi, E. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112116 · Cited by 6
Pacca-Corrêa, J. B. L., Fernandes, B. M., Siqueira, M., Schafbenker, R., Baumart, G. J., Damico, I. V., Gomes, F. C. A., & Matias, I. C. P. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04709-7 · Cited by 12
“Beyond aging, astrocytes expressing the senescence marker p16 INK4a have been reported in AD human brains and in mouse models of tau-dependent neurodegeneration [78, 79].”
A Need for Refined Senescence Biomarkers and Measures of Senolytics in the Brain
Orr, M. E. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231462 · Cited by 6
“AD-associated protein aggregation stress, e.g., tau [10–13] and amyloid-(cid:2) (A (cid:2) ) [14, 15] deposition, drives brain cell senescence.”
Qiu, O., Zhao, J., Shi, Z., Li, H., Wang, S., Liao, K., Tang, M., Xie, J., Huang, X., Zhang, W., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109698 · Cited by 8
Minné, D., Stromin, J., Docrat, T. F., Engel-Hills, P. C., & Marnewick, J. L. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.06.008 · Cited by 10
López‐Teros, M., Ávila‐Galicia, K. E., Librado‐Osorio, R., Jacinto, V. J., García, J. A., Hernández‐Montes, G., Sánchez‐Flores, A., Alarcón‐Aguilar, A., Luna‐López, A., & Königsberg, M. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70164 · Cited by 5
“…are known to contribute to neuroinflammation and cognitive decline in murine models (Salas-Venegas et al. 2023), and their presence has been shown in the brains of patients with neurodegenerative diseases, such as Alzheimer's (AD) and Parkinson's (PD) (Bhat et al. 2012; Chinta et al. 2018).”
Palomares, D., Vanparys, A., Jorgji, J., Paître, E., Kienlen‐Campard, P., & Suelves, N. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02118-5 · Cited by 9
“Furthermore, the targeted removal of senescent cells through genetic or pharmacological approaches in a tauopathy model has been shown to alleviate tau pathology, reduce neurodegeneration and improve cognitive function [18].”
Li, W., Han, Y., Wang, P., & Qiao, S. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70803 · Cited by 7
“54 In fact, the accumulation of A β and pathological tau can induce astrocyte senescence through distinct mechanisms, impairing their neuroprotective functions and accelerating disease progression.”
Stem cell-free therapy for healthy brain aging: Mechanisms, challenges, and prospects
Joshi, J. M., Verma, S. S., Seetharam, R. N., & Singh, A. K. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118676 · Cited by 6
Salminen, A. (2026) · Neurochemistry International · doi:10.1016/j.neuint.2026.106115 · Cited by 5
Telomerase Depletion Accelerates Ageing of the Zebrafish Brain
Martins, R. R., Besse, S., Ellis, P. S., Sevil, R., Hartopp, N., Purse, C., Everett‐Brown, G., Evans, O., Mughal, N., Wahib, M. H. F., et al. (2025) · Aging Cell · doi:10.1111/acel.70280 · Cited by 5
SATB1, senescence and senescence‐related diseases
Qi, W., Bai, J., Wang, R., Zeng, X., & Zhang, L. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31327 · Cited by 6
“…cells, and neurons have been identified with high levels of senescence markers such as p16, p53, p21, and SA ‐ β ‐ gal (Baker & Petersen, 2018; Bhat et al., 2012; Gaikwad et al., 2021; Garwood et al., 2014; Han et al., 2020; Holtzman & Ulrich, 2019; Hu et al., 2021; Musi et al., 2018; Naderi…”
Role of astrocytes in Alzheimer's disease pathogenesis and the impact of exercise-induced remodeling
Shao, J., Deng, Q., Feng, S., Wu, C., Liu, X., & Yang, L. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150418 · Cited by 5
Ethanol Exacerbates the Alzheimer’s Disease Pathology in the 5xFAD Mouse Model
Mohammed, H. E., Nelson, J. C., & Marshall, S. A. (2024) · Neuroglia · doi:10.3390/neuroglia5030020 · Cited by 5
“In fact, studies have shown that amyloid beta can directly lead to these senescent phenotypes in both astrocytes [17] and microglia [18].”
Santín-Márquez, R., Salas-Venegas, V., García, J. A., Librado‐Osorio, R., Luna‐López, A., López‐Díazguerrero, N. E., Gómez‐González, B., & Königsberg, M. (2025) · Biogerontology · doi:10.1007/s10522-025-10231-0 · Cited by 5
“Moreover, senescent cells have been reported in brains of patients with Alzheimer’s and Parkinson’s diseases (Bhat et al. 2012; Chinta et al. 2015).”
Physiological Roles of Hippo Signaling Pathway and Autophagy in Dementia
Christoper, A., Herman, H., Abdulah, R., Zulhendri, F., Sanjaya, A., & Lesmana, R. (2023) · Current Aging Science · doi:10.2174/1874609816666230206144212 · Cited by 5
Alzheimer's Disease: From Animal Models to the Human Syndrome
Orta‐Salazar, E., Vargas-Rodríguez, I., Castro-Chavira, S. A., Feria‐Velasco, A., & Díaz-Cintra, S. Y. (2016) · InTech eBooks · doi:10.5772/64619 · Cited by 6
“In brain, astrocytes clearly play a role in modulating neuronal function and survival in health but in disease are senescent [134].”
BackgroundAmram, S., Iram, T., Lazdon, E., Vassar, R. J., Ben‐Porath, I., & Frenkel, D. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/700013 · Cited by 10
“provided evidence that Aβ42 leads to AS (14).”
BackgroundMethodInfluentialSabetta, Z., Krishna, G., Curry, T., Adelson, P. D., & Thomas, T. C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.06.527058 · Cited by 7
“vulnerability to compromised neurons by promoting an inflammatory response after TBI [24, 83], a mechanism”
BackgroundThe emerging role of cellular senescence in amyotrophic lateral sclerosis
Tan, X., & Gao, N. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1599492 · Cited by 8
Decoding senescent drivers in Alzheimer's disease: From bench to bedside
Zhou, R., Lin, X., Liao, Z., Lin, J., Zheng, R., Ni, H., Liu, W., Feng, Z., He, Q., Lin, X., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102978 · Cited by 4
Sweeney, E. M., Abate, G., Bakker, B. R. V., Mastinu, A., Lai, Y., Uberti, D. L., Nilsson, P., & Tambaro, S. (2026) · Aging Cell · doi:10.1111/acel.70478 · Cited by 8
“This profile contrasts with in vitro findings, where Aβ42-exposed astrocytes exhibited p16 upregulation and increased SA- β-gal activity (Bhat et al. 2012), suggesting that progressive amyloid pathology may activate different senescence pathways compared to acute Aβ42 exposure in isolated cell…”
Augustin, E., Vinasco‐Sandoval, T., Riquelme‐Perez, M., Plassard, D., Gaudin, M., Aurégan, G., Mitja, J., Bernier, S., Joséphine, C., Petit, F., et al. (2025) · Glia · doi:10.1002/glia.70019 · Cited by 6
“Indeed, the number of senescent astrocytes increases through aging and AD (Bhat et al. 2012) and in Tau P301S transgenic mice (Bussian et al. 2018).”
Andersen, J. K., & Chinta, S. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-23246-1_8 · Cited by 5
A protocol for rapid construction of senescent cells
Yu, X., Quan, J., Chen, S., Yang, X., Huang, S., Yang, G., & Zhang, Y. (2022) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2022.929788 · Cited by 5
“Increased MMP3 expression also presented upregulation in cortical tissue in patients with AD (Bhat et al., 2012).”
BackgroundMitroshina, Е. V., Krivonosov, M., Pakhomov, A. M., Yarullina, L. E., Gavrish, M. S., Mishchenko, T. A., Yarkov, R. S., & Vedunova, M. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512286 · Cited by 6
“Senescent astrocytes, in particular, release SASP mediators such as IFNγ, CXCL10, IL-6, and TGFβ, which have the potential to induce inflammation [50,51].”
BackgroundImpact of aging on copper isotopic composition in the murine brain
Lahoud, E., Moynier, F., Luu, T.-H., Mahan, B., & Borgne, M. L. (2024) · Metallomics · doi:10.1093/mtomcs/mfae008 · Cited by 4
Screening Method for Identifying Toxicants Capable of Inducing Astrocyte Senescence
Woods, G., & Andersen, J. K. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy181 · Cited by 4
[The effect of deep branches of cervical nerve on motorial function of trapezius muscle].
Wang, F., Wen, Y., & Li, L. (2003) · 华西口腔医学杂志 · Cited by 4
Metabolic Reprogramming Rejuvenates Aged Myeloid Cells Restoring Cognition
Mendelsohn, A. R., & Larrick, J. W. (2021) · Rejuvenation Research · doi:10.1089/rej.2021.0004 · Cited by 4
“The senescent state has been associated with AD, 6 especially in astrocytes 7 and microglia.”
Plasma senescence associated secretory proteins: A new link to mild cognitive impairment
Banarjee, R., & Basisty, N. (2025) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2025.100561 · Cited by 4
Holloway, K., Neherin, K., Song, Y., Sato, K., Houston, A., Chen, F., Ding, L., & Zhang, H. (2025) · Aging Cell · doi:10.1111/acel.14472 · Cited by 4
“…cells (astrocytes, microglia, oligo-dendrocyte precursor cells, and neurons) in AD mouse models and human post-mortem AD brains (Arendt et al. 1996; Bhat et al. 2012; Bussian et al. 2018; Dehkordi et al. 2021; Gaikwad et al. 2021; Herdy et al. 2022; McShea et al. 1997; Musi et al. 2018; Wei et al.…”
Potential connections between senescence and chemobrain: An early overview of literature
Melhem, N. Y., Qutifan, S., Alsalem, M., & Saleh, T. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102896 · Cited by 5
Nie, P., Zhou, J., Zhang, J., Chen, J., & Zhang, J. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05452-3 · Cited by 3
Neurogliovascular alterations in brain pathologies across lifespan
Daigle, B., Bevilacqua, L. M., Noël, V. P., Lebel, M., Côté, D. C., Lévesque, L., & Ménard, C. (2024) · Glial health research. · doi:10.1016/j.ghres.2024.100004 · Cited by 4
Tsai, Y., González, E. A., Grodzki, A. C., Bruun, D. A., Saito, N. H., Harvey, D. J., & Lein, P. J. (2024) · Frontiers in Toxicology · doi:10.3389/ftox.2024.1360359 · Cited by 6
Sensory Stimulation-Induced Astrocytic Calcium Signaling in Electrically Silent Ischemic Penumbra
Nielsen, R. M., Fordsmann, J. C., Cai, C., Brazhe, A., Thomsen, K. J., & Lauritzen, M. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00223 · Cited by 3
Targeting Senescent Cells to Improve Human Health
Wijshake, T., & van Deursen, J. M. A. (2016) · Healthy ageing and longevity · doi:10.1007/978-3-319-26239-0_16 · Cited by 3
“The disease is characterized by brain atrophy, extracellular deposition of amyloid (A“) peptide, accumulation of phosphorylated tau in neurons, inflammation, and neuronal and synaptic loss (Alzheimer’s Association 2011; Bhat et al. 2012).”
BackgroundMitochondrial Haplogroup Influences Motor Function in Long-Term HIV-1-Infected Individuals
Azar, A., Devlin, K. N., Mell, J. C., Giovannetti, T., Pirrone, V., Nonnemacher, M. R., Passic, S. R., Kercher, K., Williams, J. W., Jacobson, J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163772 · Cited by 3
Self-citationAnggraini, D. R., Ilyas, S., Hasibuan, P. A. Z., Machrina, Y., Purba, A., Munir, D., Putra, I. B., & Betty, B. (2022) · Acta Informatica Medica · doi:10.5455/aim.2022.30.283-286 · Cited by 5
“Human brain tissue, with age, show increased number of astrocytes positive for p16INK4a, matrix metalloproteinase 3 (MMP3) and SASP-associated proteases (8).”
BackgroundGong, X., Lu, W., Xiao, Q., Wang, X., Cui, C., & Tang, H. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1555586 · Cited by 2
Advancing Alzheimer's disease treatment: A literature review on senolytic intervention
Onuh, V. C. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251376540 · Cited by 2
“38,39 The central role of senescent cells in AD progression, coupled with their diverse mechanisms of tissue dysfunction, has positioned cellular senescence as a promising therapeutic target.”
New frontier for epilepsy treatment through targeting cellular senescence
Bello, S. T., Rafe, M. R., & Huang, F. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111506 · Cited by 3
Neherin, K., Holloway, K., Song, Y., Houston, A., Chen, F., Ding, L., & Zhang, H. (2026) · Advanced Biology · doi:10.1002/adbi.202500468 · Cited by 3
Glover, M., Maher, J. F., & Davies, D. M. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2622794 · Cited by 3
“93 100 To counter this, assessment of senolytic drugs has been progressed to Phase I clinical trials for the treatment of Alzheimer’s disease.”
Liu, F.-Y., Huang, Y.-P., Li, Z.-Q., Li, X., Zhang, J.-S., Guan, L., & Qiao, W.-J. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1746161 · Cited by 4
“This primed state may explain why LOMG (138).”
Olinger, B., & Basisty, N. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103254 · Cited by 2
Non-ionizing radiation-induced cellular senescence and age-related diseases
Wang, H., Tong, J., & Cao, Y. (2024) · Radiation Medicine and Protection · doi:10.1016/j.radmp.2024.04.002 · Cited by 5
Senolytics Target Senescent Cells and Improve Aging and Age-Related Diseases
Buffard, T., & Ferbeyre, G. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_4 · Cited by 4
Cobalamin Deficiency May Induce Astrosenescence—An In Vitro Study
Rzepka, Z., Rok, J., Kowalska, J., Banach, K., & Wrześniok, D. M. (2022) · Cells · doi:10.3390/cells11213408 · Cited by 2
“[33] demonstrated a significant increase in senescent (p16INK4A-positive) astrocytes in the frontal cortex of AD patients compared with non-AD adult control subjects of similar ages.”
ResultThe Connection between Cellular Senescence and Age-Related Diseases
Falandry, C. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316677018.005 · Cited by 2
Swanson, E. C. (2014) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2k30f · Cited by 1
“It was also observed that the exposure of cultured normal 29 astrocytes to the β-amyloid peptide, an indicator and possible cause of AD induces senescence (Bhat et al., 2012).”
BackgroundInfluentialUncovering the Signatures of Cellular Senescence in the Human Dorsolateral Prefrontal CortexPreprint
Sloan, N., Mares, J. A., Daly, A. C., Coie, L. A., Grier, S., Barretto, N., Casel, O., Kang, K., Jackson, C., Pedersen, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.19.639091 · Cited by 3
“Senescent astrocytes positive for p16 have been shown to accumulate in the frontal cortex of Alzheimer’s disease patient brains 52 .”
Cell-to-Cell Communication in Aging: Mechanisms, Impact and Therapeutic Prospects
Mas‐Bargues, C., Sanz‐Ros, J., Huete-Acevedo, J., & Borrás, C. (2024) · Springer eBooks · doi:10.1007/978-3-031-55022-5_8 · Cited by 2
Bentolila, G., Agrawal, N., Phung, J., Van, L. M., & Trivedi, G. (2024) · Berkeley Pharma Tech Journal of Medicine · doi:10.52243/bptjm.v4i2.71 · Cited by 1
Effects of senescence on astrocyte to brain endothelial cell signaling
Guo, S., Hamanaka, G., Zhang, F., Lee, J. C. L., Park, J.-H., Li, W., Arai, K., & Lo, E. H. (2025) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.70013 · Cited by 2
“44,45 In cell culture, astrocytes can also be “ aged ” with high passages, and various characteristics of senescence can also be detected in these cells.”
Astrocyte Senescence Impairs Synaptogenesis due to Thrombospondin‐1 Loss
Ercoli, S., Casares-Crespo, L., Juárez‐Escoto, E., & Mira, H. (2026) · Aging Cell · doi:10.1111/acel.70382 · Cited by 2
“…2003; Piechota et al. 2016; Yu et al. 2017), and increased secretion of proinflammatory chemokines, cytokines, proteases and growth factors, collectively known as the senescence-associated secretory phenotype (SASP) (Coppé et al. 2008; Bhat et al. 2012; Cohen et al. 2017; Gorgoulis et al. 2019).”
Li, S., Wei, S., Wang, L., Yu, T., Wang, H., Yang, S. B., Cao, W., & Zhang, X. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151452 · Cited by 1
The Biological Mechanisms of Frailty: Focusing on Cellular Senescence
Erusalimsky, J. D. (2026) · European Cardiology Review · doi:10.15420/ecr.2025.81 · Cited by 1
Senotherapeutics: Emerging pharmacological strategies to target cellular senescence
Nagy, D., Brunner, E., Ekambaram, S., Nagaraja, R. Y., Kordestan, K. V., Patai, R., Kristóf, R., Nagykaldi, M., Chandragiri, S. S., Shanmugarama, S., et al. (2026) · Advances in Translational Research · doi:10.1556/1661.2026.00015 · Cited by 3
Cellular senescence links muscle atrophy and posttraumatic osteoarthritis after ACL injury
Keeble, A. R., Owen, A. M., Gonzalez‐Velez, S., Thomas, N. T., Brightwell, C. R., Balawender, P. J., O'Daniel, M. G., Weiss, H., Noehren, H., Thompson, H. J., et al. (2026) · Function · doi:10.1152/function.017.2026 · Cited by 1
“Cellular senescence is associated with age-related decline (58) and is implicated as a causal driver of several diseases, such as Alzheimer ’ s disease, diabetes, and osteoporosis (59 – 62).”
Wrasidlo, W., & Masliah, E. (2026) · Cells · doi:10.3390/cells15131177 · Cited by 2
“Senescent astrocytes, microglia, and oligodendrocyte progenitors have been identified in AD, PD, and FTLD-related models [111,113,190,191].”
Yao, M., Liu, A., Xing, L., Song, J., Yang, Y., Yue, X., & Li, H. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103260 · Cited by 1
Host-Pathogen Interaction as a Driver of Cellular Senescence: Microbial Triggers and Host Response
Iordache, F., Zaharie, A. A., Rosu, P. M., Holban, A. M., & Curuțiu, C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146497 · Cited by 1
Cellular senescence and inflammageing: from mechanisms to senotherapeutic interventions
Chmielewski, P. P. (2026) · Biogerontology · doi:10.1007/s10522-026-10477-2 · Cited by 3
“In neurodegeneration, senescence-like phenotypes in astrocytes, microglia, oligodendrocyte lineage cells and potentially certain post-mitotic cell populations may amplify neuroinflammation, impair proteostasis and disrupt synaptic homeostasis (Bhat et al. 2012).”
Amorim, P., Hayashide, L. D. S., Leocadio, V. E., Marques, M., Navarra, I., de Andrade, C. B. V., de Carvalho, J. J., Pinto, R. S., & Diniz, L. P. (2026) · Antioxidants · doi:10.3390/antiox15091127 · Cited by 2
“Senescent astrocytes have been identified in the context of brain aging and Alzheimer’s disease and may disrupt neuronal homeostasis by reducing metabolic and trophic support, promoting chronic inflammation, and impairing glutamate clearance [6,7].”
Metadata
- Authors
- Bhat, R., Crowe, E. P., Bitto, A., Moh, M., Katsetos, C. D., Garcia, F. U., Johnson, F. B., Trojanowski, J. Q., Sell, C., & Torres, C.
- Affiliations
- Drexel University (US)
- University of Pennsylvania (US)
- Corresponding author
- Torres, Claudio
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-09-12
- Volume
- 7
- Issue
- 9
- Pages
- e45069
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3440417
- OpenAlex
- W2026433865
- Cited by
- 586
- References
- 64
- Citations by year
- 2026: 44 · 2025: 56 · 2024: 68 · 2023: 54 · 2022: 52 · 2021: 59 · 2020: 53 · 2019: 47 · 2018: 37 · 2017: 27 · 2016: 31 · 2015: 17 · 2014: 30 · 2013: 7 · 2012: 3
- FWCI
- 12.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Drexel University
- National Institutes of Health
- University of California, San Diego
- College of Medicine, Drexel University
- National Institute on Aging (AG022443-S1, AG022443, R01AG022443)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- astrocyte senescence, Alzheimer's disease, aging, p16INK4a, MMP-1, amyloid-beta 42, oxidative stress, senescence-associated β-galactosidase, interleukin-6, p38 MAPK, neuroinflammation, frontal cortex, sporadic Alzheimer's disease
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Animals, Astrocytes, Brain, Cells, Cultured, Cricetulus, Female, Cricetinae, Humans, Male, Microscopy, Fluorescence, Middle Aged, Peptide Fragments, Immunoblotting, Biomarkers, Interleukin-6, Amyloid beta-Peptides, CHO Cells, Cellular Senescence, Cyclin-Dependent Kinase Inhibitor p16, Matrix Metalloproteinase 1, p38 Mitogen-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.